Navigation Links
Enobia Pharma Raises $40.1 Million Series B Financing
Date:9/11/2007

o was previously Vice President, Clinical Affairs, Transkaryotic Therapies Inc. Mr Silverstein has been elected Chairman of the Board of Directors.

Hypophosphatasia is caused by mutations in the gene for alkaline phosphatase, an enzyme that is essential for proper bone mineralization. The symptoms of the disorder include: growth retardation, skeletal deformities and frequent fractures. The disorder is lethal in its most severe form. Enobia is developing an enzyme replacement therapy for hypophosphatasia using a proprietary bone-targeted form of recombinant alkaline phosphatase. The Company has demonstrated promising results in a mouse model of hypophosphatasia. These results were recently presented at the Annual Meeting of the International Bone and Mineral Society (June 2007, Montreal). Additional data will be presented at the upcoming Annual Meeting of the American Society for Bone and Mineral Research (September 2007, Hawaii). Enobia anticipates initiating clinical studies in the summer 2008.

Enobia Pharma is a Montreal-based, privately held company founded in 1997. The Company is developing Enzyme Replacement Therapeutics and other compounds for the treatment of serious bone diseases.

For additional information on Enobia Pharma, please contact:

Mr. Luc Cournoyer, VP Finance

Enobia Pharma

2901 Rachel Street East, Suite 23, Montreal, Quebec, CANADA.H1W 4A4

(514) 596-2901 extension # 223

Email: luc.cournoyer@enobia.com


'/>"/>
SOURCE Enobia Pharma Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...nhua-- Pharmaxis,Ltd (AXS: ... Quarterly,Report to Shareholders on the afternoon... host an investor teleconference the following mor...stions., The teleconference will be on Thursday 1...tober at 5.30pm U.S. East Coast, 2.30pm U.S. West ...
(Date:10/12/2008)... Oct. 12 /- Mentice, Inc., a,leading ...ed medical,simulation systems and Education Manage...kills training and evaluation software solutions, ...r Therapeutics symposium in,Washington D.C., an OE...ceSIM(TM) as a standard option to its flagship Vas...
(Date:10/10/2008)...e/ -- CorMatrix Cardiovascular, Inc., an,Atlanta-b...g unique,extracellular matrix (ECM(TM)) biomateria...o repair damaged cardiovascular tissue, today anno...ic Officer, will present data,on the company,s nex...scatheter Cardiovascular Therapeutics (TCT) 2008 c...
(Date:10/10/2008)...o be Held on October 16th, SAN DIEGO, Oct. 10 /PR...RE) announced today that the company will release ...re Wednesday, October 15, 2008, and will,subsequen..., 2008,commencing at 4:30 PM ET. The conference c...nt and will be available over the Internet via liv...
Breaking Biology Technology:Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 2Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership 3CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C. 2PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 2
...rs Note: Wisconsins Department of Workforce Deve...gthening the states workforce. The department has ...bs, increase wages, address workforce shortages an...o Wisconsin workers. Secretary Roberta Gassman in ... talks about how DWD is investing in people and ho...
...EE-- ARI , a provider of business solutions that c...and distribution networks, announced today that Ha...t to license ARI,s EMPARTweb e-Catalog solution fo...okup and ordering service within their dealer webs...web, provide ongoing updates for selected manufact...
...eld, Wis.-- Fiserv Credit Processing Services se...t solutions to help ensure response time of its cr... Fiserv Credit Processing Services provides outso...s a unit of Fiserv, Inc. , ,Fiserv Credit Processi...enhances their ability to manage credit decisions,...
...s suggest 1500 Megawatts of Electricity Could Be S...e Wisconsin, especially after the California Energ... paradigm shift. There was a time when the major p...d with the utilities, the federal government and i...the environmental component of each decision made ...
Other Biology Technology:WTN Interview: Roberta Gassman 2WTN Interview: Roberta Gassman 3Wisconsins Businesses Can Become Environmental Leaders 2Wisconsins Businesses Can Become Environmental Leaders 3
(Date:10/10/2008)... , Advances in information technology have shaped...so how we make new medicines. A project just funde...ke computer-aided drug design to the next level. ,... to expand and enhance the molecular data needed t...redict potential drug candidates. The data will be...
(Date:10/10/2008)... , Shinya Yamanaka MD, PhD, of Kyoto University a...se (GICD) has taken another step forward in improv...n of induced pluripotent stem (iPS) cell technolog...lt cells can be reprogrammed to become embryonic s...e of the four genes required to reprogram the cell...
(Date:10/10/2008)... , MARSHFIELD, MILWAUKEE, MADISON Governor Jim...tween four Wisconsin research institutions to adva...e that proactively addresses diseases. The Wiscons... effort among the Marshfield Clinic, Medical Colle...ool of Medicine and Public Health (UWSMPH) and UW-...
(Date:10/10/2008)... , , The stickleback fish, Gasterosteus acul...nisms in the wild, and has been a particularly use...y, behavior, life history and morphology caused by...On biological levels from molecular and genetic to...ng with the population level, it has proven far mo...
Breaking Biology News(10 mins):New data resource to advance computer-aided drug design 2Yamanaka eliminates viral vector in stem cell reprogramming 2Governor Doyle announces historic genomic research collaboration 2Fitness in a changing world 2Fitness in a changing world 3North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 1North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 2North Castle Partners Names Dennis Lee of Octane Fitness CEO of the Year 20071 3Miller Lite Bottle Caps Equal Cash for MDA This Summer 20066 1Miller Lite Bottle Caps Equal Cash for MDA This Summer 20066 2Miller Lite Bottle Caps Equal Cash for MDA This Summer 20066 3Medtronic Unit to Pay 2475 Million to Settle Whistleblower Medicare Fraud Case 5585 1Medtronic Unit to Pay 2475 Million to Settle Whistleblower Medicare Fraud Case 5585 2Scorched Earth millenium map shows fire scars 3399 1Scorched Earth millenium map shows fire scars 3399 2
... experiments of their kind, researchers at Rice Un...n Cancer Center have determined that carbon nanotu...arch lab animals cause no immediate adverse health...re they are removed by the liver. , The findings a...ly unmodified carbon nanotubes, a revolutionary na...
...mal model, brain researchers in Göttingen have exa...n humans. These are mutations in the genes which c... neuroligin family. The study published in the sci...that neuroligins ensure that signal transmission b...tically altered mice without neuroligins, the cont...
... for targeting malignant brain tumors through indu...een developed by a team of researchers headed by a...emistry. , Alexander Levitzki, who is the Wolfs...associate, Dr. Alexei Shir, and his colleagues fro...many, have pioneered a technique in which a molecu...
...us previously used as a marker in tracing human mi...s at Penn State. Results of this study also sugges...r rates of evolution than previously thought. , "T...e in Africa," said Laura Shackelton, a postdoctora... Disease Dynamics. "But, in the case of this virus...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2When nerve cells can't make contact 2When nerve cells can't make contact 3When nerve cells can't make contact 4 Killing brain tumors from within: A 'Trojan horse' approach 2Viral marker of human migration suspect 2
...The DIGIVIEW line of digital x-ray detectors from ...adiation imaging device complete with 12 to 16 bit...s of a photodiode array sensor with pixel spacing ...w x-ray energies (10-50 kV) and an extended energy...
The Odyssey Infrared Imaging System is a complete family of products that includes the Odyssey Imager, IRDye labeling reagents and Odyssey software for scan control and data analysis.
...The desk-top XCAT 50 X-Ray System from KUBTEC is a...e two and three dimensional representation of the ...s volumetric reconstruction of specimen X-ray imag...to provide high level of detail in standard 2D ima...
...Oxidative stress is the condition in which a lack ...the various antioxidants. Oxidative stress appear...seases, including artherosclerosis, chronic inflam...ossesses several antioxidant systems that are very...
Biology Products: